Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-12

Clinical Trial Update: Role of Vit-D Supplementation on BioNTech, Pfizer Vaccine Side Effect and Immunoglobulin G Response [Phase 3]

View source ↗

Summary

Phase 3 trial investigating whether vitamin D supplementation affects vaccine side effects and IgG response to the BioNTech/Pfizer COVID-19 vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BioNTech/Pfizer vaccine (BNT162b2)
  • Vitamin D supplementation (Cholecalciferol)

Snippet

Sponsor: Sulaimani Polytechnic University | Conditions: COVID-19 Respiratory Infection | Phase 3 | Status: COMPLETED